Larimar Therapeutics, Inc.
LRMR · XNASCIK 1374690fmd_0VW7K6BQVADJYE4EMN4RJFVNEGManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2012 to Jun 30, 2026, 55 periods
AI-written
A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.
Loading